IL6 and ovarian carcinoma: Local tumor overexpression of IL-6 has been observed in colorectal, prostate, pancreatic, lung, cervical, and breast cancer as well as in renal and ovarian carcinomas, confirming the important role of this cytokine in tumor survival and progression [14].